Aptamer Group (APTA) Share Price, News & Analysis

Company Overview

Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, and internationally. The company offers Optimer platform that enables the discovery and development of oligonucleotide binders; custom development services for oligonucleotide-based aptamer and Optimer binders; solutions to bioprocessing, diagnostic, and pharmaceutical scientists; and contract research services in the field of therapeutics. It serves pharma companies, diagnostic development companies, and research institutes. Aptamer Group plc was founded in 2008 and is headquartered in York, the United Kingdom.

Key Stats

• Today's Range: 0.36 to 0.36
• 50-Day Range: 0.21 to 0.38
• 52-Week Range: 0.20 to 1.40
• Volume: 4.74 million shs
• Average Volume: 12.42 million shs
• Market Capitalization: £6.91 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

APTA Stock Analysis - Frequently Asked Questions

How have APTA shares performed this year?

Aptamer Group's stock was trading at GBX 1.15 at the start of the year. Since then, APTA shares have decreased by 68.7% and is now trading at GBX 0.36.
View the best growth stocks for 2024 here.

How do I buy shares of Aptamer Group?

Shares of APTA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:APTA
• CUSIP: N/A
• CIK: N/A
• Web: aptamergroup.com
• Phone: 44 1904 567 790
• Fax: N/A
• Employees: 37
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-7,010,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -187.53%
• Return on Assets: -44.96%

Debt

• Debt-to-Equity Ratio: 53.06
• Current Ratio: 2.14
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: £1.03 million
• Price / Sales: 6.71
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: GBX 1 per share
• Price / Book: 0.36

Miscellaneous

• Outstanding Shares: 1,920,000,000
• Free Float: N/A
• Market Cap: £6.91 million
• Optionable: Not Optionable
• Beta: -0.52